CINF 63 |
| The pharmaceutical research environment today is very different from what it was even five years ago. The demands for a robust, productive research pipeline are arguably greater now than they have ever been and with it the challenge of finding new ways to meet this demand is increasing as well. It is widely accepted that strategic in- and out-licensing is one way to augment internal efforts to generate a robust pipeline and while, in and of itself, this is not a new concept the strategies and practices that have been put in place around these licensing activities have become entrenched and may no longer be sufficient to meet the challenges of tomorrow. What we are rapidly discovering is that the best practices of yesterday and today may not necessarily be the best practices for tomorrow. As a result of the increasing globalization of research and ever more complex interplay between pharma companies, CRO's, and academia, there is rapidly emerging a requirement for new paradigms of interaction in order to ensure success for all parties. In this presentation some of the concepts and paradigm shifts around licensing that Vertex has developed and successfully implemented will be presented. |
|
Intellectual Property and Licensing
9:00 AM-12:35 PM, Wednesday, August 22, 2007 BCEC -- 251, Oral
Division of Chemical Information |